Terms: = Endocrine gland cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1 AND Prognosis
11 results:
1. Genetic diagnosis of endocrine disorders in Cyprus through the Cyprus Institute of Neurology and Genetics: an ENDO-ERN Reference Center.
Neocleous V; Fanis P; Toumba M; Skordis N; Phylactou LA
Orphanet J Rare Dis; 2024 Apr; 19(1):167. PubMed ID: 38637882
[TBL] [Abstract] [Full Text] [Related]
2. prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study.
Kruger SF; Lohneis A; Abendroth A; Berger AW; Ettrich TJ; Waidmann O; Kapp M; Steiner B; Kumbrink J; Reischer A; Haas M; Westphalen CB; Zhang D; Miller-Phillips L; Burger PJ; Kobold S; Werner J; Subklewe M; von Bergwelt-Baildon M; Kunzmann V; Seufferlein T; Siveke JT; Sinn M; Heinemann V; Ormanns S; Boeck S
ESMO Open; 2022 Feb; 7(1):100388. PubMed ID: 35121522
[TBL] [Abstract] [Full Text] [Related]
3. Clinical factors and biomarker profiles associated with patient outcome in endometrioid ovarian carcinoma - Emphasis on tumor grade.
Soovares P; Pasanen A; Similä-Maarala J; Bützow R; Lassus H
Gynecol Oncol; 2022 Jan; 164(1):187-194. PubMed ID: 34711431
[TBL] [Abstract] [Full Text] [Related]
4. UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic cancer.
Feng L; Wang Y; Qin J; Fu Y; Guo Z; Zhang J; He G; Jiang Z; Xu X; Zhou C; Gao Y
Biomed Res Int; 2021; 2021():6673125. PubMed ID: 34595239
[TBL] [Abstract] [Full Text] [Related]
5. Combined tumor epithelial and stromal histopathology with keratin 81 expression predicts prognosis for pancreatic ductal adenocarcinoma.
Park E; Yoo JE; Hwang HK; Kang CM; Lee CK; Kim MH; Bang S; Park YN
J Hepatobiliary Pancreat Sci; 2022 Feb; 29(2):250-261. PubMed ID: 34318617
[TBL] [Abstract] [Full Text] [Related]
6. Blocking the road to de-differentiation: hnf1a/KDM6A complex safeguards epithelial integrity in pancreatic cancer.
Bärthel S; Schneider G; Saur D
EMBO J; 2020 May; 39(9):e104759. PubMed ID: 32236961
[TBL] [Abstract] [Full Text] [Related]
7. hnf1a inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1.
Lu Y; Xu D; Peng J; Luo Z; Chen C; Chen Y; Chen H; Zheng M; Yin P; Wang Z
EBioMedicine; 2019 Jun; 44():403-418. PubMed ID: 31103629
[TBL] [Abstract] [Full Text] [Related]
8. Investigating the role of transcription factors of pancreas development in pancreatic cancer.
Naqvi AAT; Hasan GM; Hassan MI
Pancreatology; 2018 Mar; 18(2):184-190. PubMed ID: 29289465
[TBL] [Abstract] [Full Text] [Related]
9. Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response.
Muckenhuber A; Berger AK; Schlitter AM; Steiger K; Konukiewitz B; Trumpp A; Eils R; Werner J; Friess H; Esposito I; Klöppel G; Ceyhan GO; Jesinghaus M; Denkert C; Bahra M; Stenzinger A; Sprick MR; Jäger D; Springfeld C; Weichert W
Clin Cancer Res; 2018 Jan; 24(2):351-359. PubMed ID: 29101303
[No Abstract] [Full Text] [Related]
10. hnf1a/CASC2 regulates pancreatic cancer cell proliferation through PTEN/Akt signaling.
Yu Y; Liang S; Zhou Y; Li S; Li Y; Liao W
J Cell Biochem; 2019 Mar; 120(3):2816-2827. PubMed ID: 28865121
[TBL] [Abstract] [Full Text] [Related]
11. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.
Tsuchiya A; Sakamoto M; Yasuda J; Chuma M; Ohta T; Ohki M; Yasugi T; Taketani Y; Hirohashi S
Am J Pathol; 2003 Dec; 163(6):2503-12. PubMed ID: 14633622
[TBL] [Abstract] [Full Text] [Related]
